2021-03-02 HEPC Launch Call Meeting notes
- Andrea Price Old Account (Deactivated)
- Raymonde Uy (Unlicensed)
Date
Agenda
- Welcome, Housekeeping, and Agenda Overview
- Introductions
- Review – Where we are now?
- 2020 – 2021 Project Year
- Next Steps/Q&A and Discussion
Materials
Attendees (click on a user to see email and position title)
| NACHC Informatics Team | AlianceChicago | HCN | CDC |
|---|---|---|---|
Liesl Hagan, Epidemiologist, Prevention Branch DHHS/CDC/DDID/NCHHSTP/DVH Noele Nelson, Chief, Prevention Branch, /DHHS/CDC/DDID/NCHHSTP/DVH |
Discussion items
| Time | Item | Who | Notes | Action Items |
|---|---|---|---|---|
We are looking at HEP C codes Yes everything will be in Confluence; you will be invited to the site |
| |||
Are the CHCs using lab testing for screening and if it is positive, it xxx to the RNA? Andrew: result went to the specific LOINC code to the antibody test rather than the RNA test (someone correct this please!!) CHCs should be advised to order the reflex? reflux This is an example of QI opportunities Sustained bio-resistance testing - usually treatment is not considered successful until you get the lab test back. Can a person be re-infected with HEPC? Theoretically yes, but it is not often seen. In pilot, diagnosis might have happened at the CHC but treatment and medical record information with with another practitioner outside of CHC. Locally-treated patients would have these data. They may be treated by a specialist, and then come to CHC 4 months later - are they asked to get re-tested? | ||||
test rather than the - combine with the RNA test and result in shortening the cascade. Liesl's slide showed that it was combined - tested as one stack.Dear Confluence Users, If you need support for use of Atlassian tools, please contact informatics@nachc.com whether you have technical issues, need feature assistance, or simply have questions.